Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy
By
- AMS
posted
May 25, 2020 10:53 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
- AMS
Added Jun 19, 2020
Blog Entry
Delay Surgery By 7 Weeks After Covid Diagnosis: Study
- AMS
Added Apr 21, 2021
Blog Entry
The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian Red-Zone
- AMS
Added Jul 07, 2020
Blog Entry
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies
- AMS
Added Aug 04, 2020
Blog Entry
Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas
- AMS
Added Jul 09, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic